EVAR Endoleaks - Types, Detection, and Management

Key Points

• Endoleak type determines urgency and treatment.
• Type I and III leaks expose the aneurysm sac to high pressure and usually require prompt repair.
• Type II endoleaks are often observed when the sac is stable or shrinking.
• Sac enlargement with a presumed type II leak should prompt treatment consideration and a search for occult type I or III leak.
• Type IV graft porosity leaks are uncommon with modern devices.
• Type V endotension is a diagnosis of exclusion in an enlarging sac without visible leak.
• CTA, duplex, and contrast-enhanced ultrasound each have roles in surveillance.
• New pain or shock after EVAR must raise concern for rupture even if previous surveillance was reassuring.

Algorithm

1. Review EVAR device, implantation date, prior sac measurements, and prior endoleaks.
2. Assess current aneurysm sac diameter and compare with serial imaging.
3. Classify visible endoleak by source and evaluate graft migration or component separation.
4. Treat type I or III endoleak promptly with endovascular repair or open conversion when needed.
5. Observe uncomplicated type II endoleak when the sac is stable or decreasing.
6. For enlarging sac with type II leak, consider branch embolization and exclude occult high-pressure leaks.
7. For sac expansion without visible leak, obtain expert imaging to evaluate endotension or missed leak.
8. Continue lifelong device and sac surveillance after treatment.

Clinical Synopsis & Reasoning

Post-EVAR surveillance is designed to detect endoleak, endograft migration, limb problems, and aneurysm sac enlargement before rupture. Endoleaks are classified by source. Type I is inadequate seal at a proximal or distal attachment site. Type II is retrograde sac filling from branch vessels such as lumbar arteries or the inferior mesenteric artery. Type III reflects component separation or fabric disruption. Type IV is flow through graft porosity, now uncommon with modern devices. Type V, often called endotension, describes sac expansion without a demonstrable leak after other causes have been excluded.

The clinical significance is not equal across types. Type I and III endoleaks expose the sac to systemic arterial pressure and carry meaningful rupture risk. They should be considered treatment failures rather than benign imaging findings. Type II is the most common form and frequently resolves spontaneously. The key issue is whether the sac remains stable or shrinks versus enlarges over serial examinations. A persistent type II leak with meaningful sac growth warrants evaluation for treatment and also re-examination for an occult type I or III source.

CTA is a standard diagnostic modality, often using arterial and delayed phases when endoleak characterization is needed. Duplex ultrasound and contrast-enhanced ultrasound can reduce radiation and nephrotoxic contrast exposure in suitable surveillance programs. Plain radiographs can identify component separation or migration but cannot evaluate the sac. New abdominal or back pain, hypotension, or evidence of sac rupture after EVAR is an emergency regardless of prior surveillance findings.

Treatment Strategy & Disposition

Type I endoleaks usually require prompt endovascular correction of the seal zone, which may include balloon molding, proximal or distal extension cuffs, endoanchors in selected anatomy, iliac extensions, branch-device strategies, or conversion to open repair when an adequate seal cannot be achieved. Type III leaks require restoration of graft integrity with bridging components, relining, or open conversion when endovascular repair is not durable or feasible.

Type II endoleaks without sac enlargement are generally managed with surveillance. When the sac expands, treatment can target the feeding and draining branch network using transarterial, translumbar, transcaval, or other embolization approaches. Merely occluding a proximal feeding artery may fail if the sac behaves as a collateral circuit. Persistent sac enlargement after apparently successful embolization should prompt reassessment for an occult high-pressure leak. Type IV leaks are usually early and self-limited with current grafts, while suspected endotension requires exclusion of missed endoleak and device problems before considering relining or open treatment.

Any patient with suspected post-EVAR rupture needs immediate vascular surgery activation, resuscitation, and urgent anatomic assessment or direct operative/endovascular control according to physiology. Long-term surveillance remains essential after every intervention because correcting one endoleak does not eliminate risks of later migration, component failure, new endoleak, or sac enlargement.

Epidemiology / Risk Factors

• Type II is the most frequently encountered endoleak after EVAR.
• Type I and III leaks are less common but carry greater rupture concern.
• Modern low-porosity grafts have made clinically relevant type IV leak uncommon.
• Late endoleaks can occur years after apparently successful EVAR.

Investigations

Endoleak Types

Pharmacology

Prognosis / Complications

• Stable or resolving type II leaks often have a favorable course.
• Untreated persistent type I or III leak increases aneurysm rupture risk.
• Continued sac enlargement despite treatment predicts the need for further investigation or intervention.
• Adherence to surveillance is central to preventing late catastrophic device failure.

Patient Education / Counseling

• Explain that EVAR requires lifelong imaging even when the aneurysm was successfully excluded.
• Patients should know their device type and keep vascular follow-up appointments.
• New sudden abdominal, flank, or back pain after EVAR warrants urgent evaluation.
• Kidney disease does not mean surveillance should stop; alternative imaging strategies can be used.
• Smoking cessation and cardiovascular risk reduction remain important after aneurysm repair.

Notes

An endoleak report should always be interpreted together with aneurysm-sac trajectory and device anatomy. Calling every persistent sac blush a reason for embolization exposes patients with benign type II leaks to unnecessary procedures, while assuming every enlarging sac is "just type II" can miss a dangerous seal failure.

The 2024 ESVS aneurysm guideline continues to emphasize surveillance after EVAR and differentiation of high-pressure endoleaks from lower-pressure branch leaks. Local surveillance intervals vary by initial postoperative imaging, device instructions, anatomy, and risk profile.

References

1. 2024 ESVS Clinical Practice Guidelines on Abdominal Aorto-Iliac Artery Aneurysms — Link